Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateBusiness Wire • 03/11/21
Lineage Cell Therapeutics Raises $35.9 Million From Sales of Marketable Securities Holdings and an At-the-Market Equity OfferingBusiness Wire • 03/08/21
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021Business Wire • 03/01/21
Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021Business Wire • 02/23/21
Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord InjuryBusiness Wire • 02/08/21
Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant ProgramsBusiness Wire • 01/21/21
Is the Options Market Predicting a Spike in Lineage Cell Therapeutics (LCTX) Stock?Zacks Investment Research • 12/14/20
Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020Business Wire • 12/09/20
Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord InjuryBusiness Wire • 12/08/20
Lineage: OPC1, VAC2, And OpRegen Are Making Progress With Several 2020 Catalysts, 48% UpsideSeeking Alpha • 11/18/20
Lineage Cell Therapeutics Presents New OpRegen® Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual MeetingBusiness Wire • 11/16/20
Lineage Cell Therapeutics Proudly Supports Patients' Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14Business Wire • 11/13/20
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular DegenerationBusiness Wire • 11/11/20
Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
Lineage Cell Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business UpdateBusiness Wire • 11/04/20
Lineage Cell Therapeutics to Host Expert Call Following OpRegen® Data Update at 2020 American Academy of Ophthalmology MeetingBusiness Wire • 11/02/20
Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020Business Wire • 10/28/20
OpRegen Data Update to Be Featured in Presentation by Christopher D. Riemann, MD at 2020 American Academy of Ophthalmology MeetingBusiness Wire • 10/15/20
Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung CancerBusiness Wire • 10/13/20
Lineage Cell Therapeutics to Present at FORCE Wealth Virtual Fireside Chat on September 23, 2020Business Wire • 09/17/20
Lineage Cell Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and at Cantor Virtual Global Healthcare Conference on September 17, 2020Business Wire • 09/10/20